PMGC Holdings (ELAB) Non Operating Investment Income (2025 - 2026)
PMGC Holdings (ELAB) posted Non Operating Investment Income of $37587.0 for Q1 2026, up 116.74% sequentially from -$224481.0 in Q4 2025.
PMGC Holdings (ELAB) Non Operating Investment Income (2025 - 2026) Analysis & Trends
PMGC Holdings has reported Non Operating Investment Income for 2 years, with the latest figure at $37587.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 | -32,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,587.00 |
| Mar 31, 2026 | 37,587.00 |
| Dec 31, 2025 | -224,481.00 |
| Dec 31, 2025 | -224,481.00 |
| Sep 30, 2025 | -25,871.00 |
| Sep 30, 2025 | -25,871.00 |